Prevalence of diabetes and glycemic control in Mexico, Ensanut 2021-2024 Prevalencia de diabetes y control glucémico en México, Ensanut 2021-2024
Academic Article in Scopus
Objective. To estimate the prevalence of type 2 diabetes (T2D), medical care, pharmacological treatment, and glycemic control in Mexico at national, regional, and state levels. Materials and methods. Data from the Encuesta Nacional de Salud y Nutrición Continua 2021-2024 were used to estimate the prevalence of total-, diagnosed-, and undiagnosed-T2D, and prevalence of medical care, treatment, and glycemic control (HbA1c <7%), stratified by sociodemographic variables. Results. National T2D prevalence was 17.0%, with 11.6% previously diagnosed and 5.4% undiagnosed. Durango and Campeche had the highest diagnosed prevalence (~16%). Central and North-Pacific regions reported the highest total (21.1 and 20.7%) and undiagnosed (8.1 and 7.3%) T2D prevalences. Among diagnosed population, 73.0% received medical care, 90.9% were under treatment, and 33.0% achieved glycemic control, with the lowest proportions in Central-Pacific, Mexico City and Peninsula (<30%). Conclusion. Findings reveal geographic disparities and underscore the need for policies focused on early detection, sustained care, and effective glycemic control of T2D in Mexico.
